myelodysplastic syndromes (MDS) | Page 15 | Aplastic Anemia and MDS International Foundation

myelodysplastic syndromes (MDS)

Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?

Author(s): 
Bigenwald C, Harel S, Chevignon F, Roos-Weil D, Bernard OA, Amorim S, Brice P, Adès L, Nloga AM, Sébert M, Braun T, Eclache V, Thieblemont C, Fenaux P
Primary Author: 
Bigenwald C
Journal Title: 
Br J Haematol
Original Publication Date: 
Sep 2016

No abstract available.

Bone Marrow Diseases: 

Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not MLL gene

Author(s): 
Zuo W, Wang SA, DiNardo C, Yabe M, Li S, Medeiros LJ, Tang G
Primary Author: 
Zuo W
Journal Title: 
J Clin Pathol
Original Publication Date: 
Aug 2016

AIMS:

Chromosome 11q23 translocations, resulting in MLL (KMT2A) rearrangement, have been well characterised in acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL). However, little is known of haematopoietic neoplasms associated with 11q23 translocation but without MLL rearrangement (11q23+/MLL-). The aim of this study is to characterise such cases with 11q23+/MLL-.

Bone Marrow Diseases: 

Myelodysplastic Syndromes in Adolescent Young Adults: One Institution's Experience

Author(s): 
Grabska J, Shah B, Reed D, Al Ali N, Padron E, Ramadan H, Lancet J, List A, Komrokji R
Primary Author: 
Grabska J
Journal Title: 
Clin Lymphoma Myeloma Leuk.
Original Publication Date: 
Aug 2016

INTRODUCTION:

There has been little improvement in cancer survival of adolescent and young adult (AYA) patients, aged 18 to 39 years, possibly reflecting different disease biology. Myelodysplastic syndrome (MDS) is mainly a disease of the elderly. The characteristics, outcomes, and response to treatment are not well described in the AYA population.

Bone Marrow Diseases: 

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)

Author(s): 
Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, Chiang YC, Liu MC, Liu CW, Kuo YY, Wu SJ, Liao XW, Lin CT, Ko BS, Chen CY, Hsu SC, Li CC, Huang SY, Yao M, Tang JL, Tsay W, Liu CY, Tien HF
Primary Author: 
Yao CY
Journal Title: 
Oncotarget
Original Publication Date: 
Aug 2016

Bone Marrow Diseases: 

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.

Author(s): 
Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H
Primary Author: 
Steensma DP
Journal Title: 
BMC Cancer
Original Publication Date: 
Aug 2016

BACKGROUND:

Bone Marrow Diseases: 

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol

Author(s): 
Mittelman M, Filanovsky K, Ofran Y, Rosenbaum H, Raanani P, Braester A, Goldschmidt N, Kirgner I, Herishanu Y, Perri C, Ellis M, Oster HS; Israel Myelodysplastic Syndrome Working Group
Primary Author: 
Mittelman M
Journal Title: 
Ann Hematol
Original Publication Date: 
Aug 2016

Bone Marrow Diseases: 

San Diego

Thank you for attending the 2016 San Diego Patient and Family Conference.

Event Date: 
Sat, 09/17/2016 -
8:30am to 4:30pm
Conference Event Type: